Currently the best $600 racing wheel you can buy. You get powerful force feedback and a smoother drive than Thrustmaster rivals. PC Gamer's got your back Our experienced team dedicates many hours to ...
BMW M is celebrating its 50th anniversary this year and we can’t think of a better way to mark the occasion than the announcement of a new M4 CSL (Competition Sport Lightweight). While the M3 ...
When Fanatec revealed last year that it was bringing a direct drive wheel base to market for just $350, sim racers sort of lost it. Direct drive is the cream of the crop in terms of force feedback ...
Drivers who appreciate an eight-cylinder engine's deep rumble rightly lament the V-8's modern downfall, but the perhaps unexpected upside is a proliferation of powerful I-6 engines that have found ...
A rare 2023 BMW M4 CSL with only 1,600 miles is up for sale on Bring a Trailer. This lightweight, high-performance coupe looks almost new and demands attention. The Ultimate Driving Machine never ...
One tour around the BMW M4 CSL is all you need to size it up. With its Michelin Pilot Sport Cup 2 R tires, prominent ducktail spoiler, and deep front splitter, the CSL is clearly a track-focused ...
We are closer to the demise of legally buying a new ICE vehicle in California (13 years) than we are to the initial introduction of the Tesla Roadster (15 years). Despite this, the internal combustion ...
CSL shares are down roughly 40% since acquiring Vifor in August 2022, an iron deficiency and kidney disease business and the largest acquisition in its history. However, several other factors have ...
It's easy to match the overall market return by buying an index fund. While individual stocks can be big winners, plenty more fail to generate satisfactory returns. Unfortunately the CSL Limited ...
hen a young go-getter named Brian McNamee took the reins in 1990 at what would one day become Australia’s third-largest listed company, the now global biotech giant CSL was barely worth the land its ...
CSL Limited is one of the largest global biotechnology companies globally that specializes in the research, development, and manufacturing of plasma-based therapies, vaccines, and other pharmaceutical ...
CSL (ASX:CSL) has had a rough three months with its share price down 17%. However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback